Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • wild typeRemove wild type filter
    Clear all

    Article Type

    • Research Article4
    • Rapid Communication1
    • Review Article1

    Publication Date

    Author

    • Aguilera, Paula1
    • Al-Olabi, Lara1
    • Atherton, David J1
    • Aubert, Hélène1
    • Badenas, Celia1
    • Bagazgoitia, Lorea1
    • Barbarot, Sébastien1
    • Beer, Hans-Dietmar1
    • Borgogna, Cinzia1
    • Bourrat, Emmanuelle1
    • Cabré, Eduard1
    • Calati, Federica1
    • Chiaverini, Christine1
    • Chong, W Kling1
    • Chu, Ruiyin1
    • Davies, Kelli-Jo1
    • Duffourd, Yannis1
    • Fabra, Àngels1
    • Ferreres, Josep R1
    • Fraefel, Cornel1
    • French, Lars E1
    • Gariglio, Marisa1
    • Glover, Mary1
    • Groesser, Leopold1
    • Hadj-Rabia, Smail1

    Journal

    • Journal of Investigative Dermatology6

    Keyword

    • WT4
    • ERK2
    • extracellular signal-regulated kinase2
    • MAPK2
    • mitogen-activated protein kinase2
    • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid1
    • Ab1
    • AIM21
    • AK1
    • ASC1
    • BAPTA1
    • CHR1
    • DNA1
    • EV1
    • GTP1
    • HF1
    • HPV1
    • HSV1
    • ICP1
    • IFE1
    • IFI161
    • KSC1
    • MEK1
    • MVA1

    Access Filter

    • Open Access

    Melanoma

    6 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Article Tumor Biology
      Open Access

      HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion

      Journal of Investigative Dermatology
      Vol. 137Issue 10p2208–2216Published online: June 5, 2017
      • Simone Lanfredini
      • Carlotta Olivero
      • Cinzia Borgogna
      • Federica Calati
      • Kathryn Powell
      • Kelli-Jo Davies
      • and others
      Cited in Scopus: 22
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        β-Human papillomaviruses (HPVs) cause near ubiquitous latent skin infection within long-lived hair follicle (HF) keratinocyte stem cells. In patients with epidermodysplasia verruciformis, β-HPV viral replication is associated with skin keratosis and cutaneous squamous cell carcinoma. To determine the role of HF keratinocyte stem cells in β-HPV-induced skin carcinogenesis, we utilized a transgenic mouse model in which the keratin 14 promoter drives expression of the entire HPV8 early region (HPV8tg).
        HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion
      • Original Article Melanocytes/Melanoma
        Open Archive

        AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy

        Journal of Investigative Dermatology
        Vol. 137Issue 6p1297–1310Published online: February 7, 2017
        • Joan Anton Puig-Butille
        • Antònia Vinyals
        • Josep R. Ferreres
        • Paula Aguilera
        • Eduard Cabré
        • Gemma Tell-Martí
        • and others
        Cited in Scopus: 34
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          The cell cycle-related genes AURKA and FOXM1 are overexpressed in melanoma. We show here that AURKA overexpression is associated with poor prognosis in three independent cohorts of melanoma patients and correlates with the presence of genomic amplification of AURKA locus and BRAFV600E mutation. AURKA overexpression may also be driven by increased promoter activation through elements such as ETS and FOXM1 found within the 5′ proximal promoter region. Activated MAPK/ERK signaling pathway mediates robust AURKA promoter activation, thereby knockdown of BRAFV600E and ERK inhibition results in reduced AURKA transcription and expression.
          AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy
        • Letter to the Editor
          Open Archive

          CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice

          Journal of Investigative Dermatology
          Vol. 137Issue 4p982–985Published online: January 23, 2017
          • Jillian M. Richmond
          • Elizabeth Masterjohn
          • Ruiyin Chu
          • Jennifer Tedstone
          • Michele E. Youd
          • John E. Harris
          Cited in Scopus: 49
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Vitiligo is a disfiguring skin disease in which melanocytes with intrinsic abnormalities are targeted and destroyed by autoreactive CD8+ T cells in the epidermis, resulting in patchy depigmentation (Palermo et al., 2001; van den Boorn et al., 2009, and reviewed in Richmond et al., 2013). Although it is one of the most common autoimmune diseases, affecting 1% of the population worldwide, there are no Food and Drug Administration-approved treatments. Previous work from our lab has shown that CD8+ T-cell recruitment to the skin in a mouse model of vitiligo is dependent on IFNγ (Harris et al., 2012) and the downstream CXCR3 chemokine system (Rashighi et al., 2014).
            CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice
          • Review
            Open Archive

            RASopathy Gene Mutations in Melanoma

            Journal of Investigative Dermatology
            Vol. 136Issue 9p1755–1759Published online: May 25, 2016
            • Ruth Halaban
            • Michael Krauthammer
            Cited in Scopus: 21
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Next-generation sequencing of melanomas has unraveled critical driver genes and genomic abnormalities, mostly defined as occurring at high frequency. In addition, less abundant mutations are present that link melanoma to a set of disorders, commonly called RASopathies. These disorders, which include neurofibromatosis and Noonan and Legius syndromes, harbor germline mutations in various RAS/mitogen-activated protein kinase signaling pathway genes. We highlight shared amino acid substitutions between this set of RASopathy mutations and those observed in large-scale melanoma sequencing data, uncovering a significant overlap.
              RASopathy Gene Mutations in Melanoma
            • Original Article Genetics
              Open Access

              Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis

              Journal of Investigative Dermatology
              Vol. 136Issue 4p770–778Published online: January 14, 2016
              • Anna C. Thomas
              • Zhiqiang Zeng
              • Jean-Baptiste Rivière
              • Ryan O’Shaughnessy
              • Lara Al-Olabi
              • Judith St.-Onge
              • and others
              Cited in Scopus: 117
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                Common birthmarks can be an indicator of underlying genetic disease but are often overlooked. Mongolian blue spots (dermal melanocytosis) are usually localized and transient, but they can be extensive, permanent, and associated with extracutaneous abnormalities. Co-occurrence with vascular birthmarks defines a subtype of phakomatosis pigmentovascularis, a group of syndromes associated with neurovascular, ophthalmological, overgrowth, and malignant complications. Here, we discover that extensive dermal melanocytosis and phakomatosis pigmentovascularis are associated with activating mutations in GNA11 and GNAQ, genes that encode Gα subunits of heterotrimeric G proteins.
                Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis
              • Original Article Immunology/Infection
                Open Archive

                IFN-γ Primes Keratinocytes for HSV-1–Induced Inflammasome Activation

                Journal of Investigative Dermatology
                Vol. 136Issue 3p610–620Published online: December 28, 2015
                • Gerhard E. Strittmatter
                • Jennifer Sand
                • Marlies Sauter
                • Michael Seyffert
                • Robin Steigerwald
                • Cornel Fraefel
                • and others
                Cited in Scopus: 36
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  Inflammasomes are immune complexes that induce an inflammatory response upon sensing of different stress signals. This effect is mainly mediated by activation and secretion of the proinflammatory cytokines proIL-1β and -18. Here we report that infection of human primary keratinocytes with the double-stranded DNA viruses modified vaccinia virus Ankara (MVA) or herpes simplex virus type 1 (HSV-1)-induced secretion of mature IL-1β and -18. This secretion was dependent on several inflammasome complexes; however, the absent in melanoma 2 (AIM2) inflammasome, which is activated by binding of double-stranded DNA, played the most important role.
                  IFN-γ Primes Keratinocytes for HSV-1–Induced Inflammasome Activation
                Page 1 of 1

                Login to your account

                Show
                Forgot password?
                Don’t have an account?
                Create a Free Account

                If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                Cancel
                • Home
                • Articles & Issues
                • Articles In Press
                • Current Issue
                • List of Issues
                • Meeting Abstracts
                • Supplements
                • Authors
                • About Open Access
                • Submit a Manuscript
                • Welcome, Authors!
                • Information for Authors
                • Information for Authors - PDF Download
                • Contact
                • Permissions
                • Reviewers
                • Information for Reviewers
                • Reviewer Login
                • Journal Info
                • About the Journal
                • About Open Access
                • Contact the Editorial Office
                • Editorial Board
                • Abstracting/Indexing
                • Access Instructions
                • New Content Alerts
                • Submit a Manuscript
                • Why Publish in JID?
                • Collections
                • Atopic Dermatitis
                • Cover Gallery
                • Itch
                • JAAD / JID Junction
                • Landmarks in Cutaneous Biology
                • Melanoma
                • Methods and Techniques for Skin Research
                • Montagna Symposium on the Biology of Skin
                • Pemphigus & Pemphigoid
                • Progress in Translational Research
                • Psoriasis
                • Resources for Clinical Research in the JID
                • News
                • Society/Journal News
                • Advertisers
                • SID
                • SID Member Activation
                • SID Website
                • Join SID
                • Annual Meeting
                • Academic Industry Partnership
                • ESDR
                • ESDR Website
                • Join ESDR
                • Awards
                • Events
                • Media
                • Education
                • JAAD / JID Junction - NEW!
                • Companion Titles
                • Journal of Investigative Dermatology Symposium Proceedings
                • JID Innovations
                • Follow Us
                • Facebook
                • Twitter

                The content on this site is intended for healthcare professionals.



                We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                • Privacy Policy  
                • Terms and Conditions  
                • Accessibility  
                • Help & Contact

                RELX